Pacira BioSciences' Return on Capital Employed rose 8.00% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 8.00%. This contributed to the annual value of -0.06% for FY2024, which is 12.00% down from last year.
Per Pacira BioSciences' latest filing, its Return on Capital Employed stood at 0.03% for Q3 2025, which was up 137.96% from -0.08% recorded in Q2 2025.
Pacira BioSciences' Return on Capital Employed's 5-year high stood at 0.09% during Q3 2021, with a 5-year trough of -0.08% in Q2 2025.
Over the past 3 years, Pacira BioSciences' median Return on Capital Employed value was 0.03% (recorded in 2023), while the average stood at 0.00%.
Data for Pacira BioSciences' Return on Capital Employed shows a peak YoY increase of 8bps (in 2025) and a maximum YoY decrease of 14bps (in 2025) over the last 5 years.
Quarterly analysis of 5 years shows Pacira BioSciences' Return on Capital Employed stood at 0.08% in 2021, then declined by 4bps to 0.04% in 2022, then grew by 2bps to 0.06% in 2023, then decreased by 12bps to -0.06% in 2024, then grew by 8bps to 0.03% in 2025.
Its last three reported values are 0.03% in Q3 2025, -0.08% for Q2 2025, and -0.07% during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value